Abstract:Diabetes mellitus is an increasingly prevalent chronic metabolic disease characterized by prolonged hyperglycemia that leads to long-term health consequences. It is estimated that impaired healing of diabetic wounds affects approximately 25% of all patients with diabetes mellitus, often resulting in lower limb amputation, with subsequent high economic and psychosocial costs. The hyperglycemic environment promotes the formation of biofilms and makes diabetic wounds difficult to treat. In this review, we present… Show more
“…Loss of VEGF may be one of the main reasons for reduced neovascularization and delayed wound healing in diabetic patients. Platelet colorectal cancer cell adhesion molecule-31 (CD31) is expressed in close connection of skin endothelial cells, which is involved in angiogenesis [ 25 ]. Therefore, CD31 can also indicate the level of angiogenesis.…”
Wound healing in diabetic patients is a difficult problem to be solved at present. In addition, patients with diabetes have an increased risk of postoperative wound complications. “She-Xiang-Yu-Hong” (SXYH) ointment is a type of traditional Chinese medicine (TCM) compound used to treat wounds. Over the past few years, SXYH has been applied in the Affiliated Hospital of Chengdu University of TCM (Chengdu, China) for the treatment of diabetic foot infections and bedsores, whereas there has been rare research on the effect of SXYH ointment on wound healing. In this study, SXYH ointment was first applied to streptozotocin (STZ)-triggered diabetic ICR mice (4–6 weeks, 20 ± 2 g) to observe the accelerated wound healing and the shortened wound healing period. As indicated by the histology and biochemistry analyses of skin biopsies, the wounds treated using SXYH ointment showed an increase in the granulation tissue. Moreover, SXYH also modulated the inflammation response by regulating affinity proinflammatory cytokines release (e.g., IL-6 and TNF-α). Furthermore, SXYH ointment obviously improved collagen fiber deposition and tissue on the wound surface. On the whole, this study indicated that SXYH ointment could accelerate wound healing, promote blood vessel formation, and suppress inflammations. Thus, the clinical potential of SXYH ointment was demonstrated in the treatment of diabetes and refractory wounds.
“…Loss of VEGF may be one of the main reasons for reduced neovascularization and delayed wound healing in diabetic patients. Platelet colorectal cancer cell adhesion molecule-31 (CD31) is expressed in close connection of skin endothelial cells, which is involved in angiogenesis [ 25 ]. Therefore, CD31 can also indicate the level of angiogenesis.…”
Wound healing in diabetic patients is a difficult problem to be solved at present. In addition, patients with diabetes have an increased risk of postoperative wound complications. “She-Xiang-Yu-Hong” (SXYH) ointment is a type of traditional Chinese medicine (TCM) compound used to treat wounds. Over the past few years, SXYH has been applied in the Affiliated Hospital of Chengdu University of TCM (Chengdu, China) for the treatment of diabetic foot infections and bedsores, whereas there has been rare research on the effect of SXYH ointment on wound healing. In this study, SXYH ointment was first applied to streptozotocin (STZ)-triggered diabetic ICR mice (4–6 weeks, 20 ± 2 g) to observe the accelerated wound healing and the shortened wound healing period. As indicated by the histology and biochemistry analyses of skin biopsies, the wounds treated using SXYH ointment showed an increase in the granulation tissue. Moreover, SXYH also modulated the inflammation response by regulating affinity proinflammatory cytokines release (e.g., IL-6 and TNF-α). Furthermore, SXYH ointment obviously improved collagen fiber deposition and tissue on the wound surface. On the whole, this study indicated that SXYH ointment could accelerate wound healing, promote blood vessel formation, and suppress inflammations. Thus, the clinical potential of SXYH ointment was demonstrated in the treatment of diabetes and refractory wounds.
“…O pé diabético se apresenta como uma das mais comuns complicações dos pacientes com diabetes mellitus (DM), que associado a um processo de cicatrização prejudicado por essa comorbidade, se torna porta de entrada para desenvolvimento de infecções 6 . Estudos indicam que entre um e três, a cada cinco pacientes com DM, irão desenvolver feridas de difícil cicatrização, como um pé diabético 7 .…”
Section: Discussionunclassified
“…Em pacientes com DM, a hiperglicemia prejudica o fechamento das lesões cutâneas por conta dos processos de inflamação e infecção, elevado estresse oxidativo, neuropatia e complicações microvasculares, além do desenvolvimento de aterosclerose. Essas condições dificultam a circulação normal, impedindo a chegada de nutrientes necessários para a recuperação, em adição com a disfunção de células endoteliais aumentado pela HAS, obstando o processo de cicatrização dessas feridas 7 .…”
Objetivo: definir o perfil clínico e epidemiológico de pacientes com lesões cutâneas hospitalizados em uma unidade de internação de clínica médica. Métodos: estudo transversal, com participação de 50 pacientes com lesões cutâneas. Dados coletados através de aplicação de questionário e analisados por meio de estatística descritiva e associação no programa SPSS. Resultados: houve predominância de pacientes do sexo masculino, com idade média de 55 anos, com lesões decorrentes de pé diabético, com presença de comorbidades como a diabetes mellitus e hipertensão arterial sistêmica, em uso de antibióticos, tempo de internação superior a um mês e com lesões caracterizadas pela presença de edema e dor. Conclusões: a caracterização dos pacientes acometidos com lesões cutâneas, através da avaliação dos aspectos sociodemográficos e clínicos, contribui na elaboração e implementação do cuidado integral, sistematizado e humanizado
“…Chronic wounds develop when normal wound healing is delayed or disrupted by different underlying pathological mechanisms, such as continuous inflammation, persistent infections, and necrosis (Raziyeva et al, 2021). Besides, chronic wounds are associated with the impairment of the following processes: growth factor production, angiogenic response, macrophage differentiation, collagen production, epidermal barrier function, granulation tissue formation, keratinocyte and fibroblast migration/proliferation, and bone healing (osteomyelitis has been reported as a predictor of inadequate wound healing and amputation (Burgess et al, 2021)). Compared with normal wound healing, chronic wounds are characterized by changes in the healing phases, as follows: 1) during hemostasis, the hypercoagulability and the decrease in fibrinolysis are altered (Erem et al, 2005); 2) during the inflammatory stage, there is an imbalance of inflammatory cytokines such as interleukin (IL)-1 (IL1), IL6, tumor necrosis factor-alpha (TNF-α), and interferon gamma (IFN-γ), as well as several growth factors, such as platelet derived growth factor (PDGF), epidermal growth factor (EGF), and insulin-like growth factor 1 (IGF-1) (Pradhan et al, 2009); 3) fibroblast and keratinocyte migration and proliferation are diminished; and 4) an imbalance between the accumulation of ECM components and their remodeling by MMPs (Brem and Tomic-Canic, 2007) (Figure 2).…”
The absence or damage of a tissue is the main cause of most acute or chronic diseases and are one of the appealing challenges that novel therapeutic alternatives have, in order to recover lost functions through tissue regeneration. Chronic cutaneous lesions are the most frequent cause of wounds, being a massive area of regenerative medicine and tissue engineering to have efforts to develop new bioactive medical products that not only allow an appropriate and rapid healing, but also avoid severe complications such as bacterial infections. In tissue repair and regeneration processes, there are several overlapping stages that involve the synergy of cells, the extracellular matrix (ECM) and biomolecules, which coordinate processes of ECM remodeling as well as cell proliferation and differentiation. Although these three components play a crucial role in the wound healing process, the ECM has the function of acting as a biological platform to permit the correct interaction between them. In particular, ECM is a mixture of crosslinked proteins that contain bioactive domains that cells recognize in order to promote migration, proliferation and differentiation. Currently, tissue engineering has employed several synthetic polymers to design bioactive scaffolds to mimic the native ECM, by combining biopolymers with growth factors including collagen and fibrinogen. Among these, decellularized tissues have been proposed as an alternative for reconstructing cutaneous lesions since they maintain the complex protein conformation, providing the required functional domains for cell differentiation. In this review, we present an in-depth discussion of different natural matrixes recently employed for designing novel therapeutic alternatives for treating cutaneous injuries, and overview some future perspectives in this area.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.